Compounds > 3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine
Page last updated: 2024-09-03

3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine and Cardiovascular Stroke

3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine has been researched along with Cardiovascular Stroke in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dixon, IM; Hata, T; Makino, N; Sugano, M; Yanaga, T1

Other Studies

1 other study(ies) available for 3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine and Cardiovascular Stroke

ArticleYear
Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats.
    Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Hemodynamics; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin

1996